Your browser doesn't support javascript.
loading
Commercial Devices-Based System Designed to Improve the Treatment Adherence of Hypertensive Patients.
da Silva, Vandermi João; da Silva Souza, Vinicius; Guimarães da Cruz, Robson; Mesquita Vidal Martinez de Lucena, Juliana; Jazdi, Nasser; Ferreira de Lucena Junior, Vicente.
Afiliação
  • da Silva VJ; Federal University of Amazonas, UFAM-PPGI, Manaus-Amazonas 69067-005, Brazil. vandermisilva@gmail.com.
  • da Silva Souza V; Federal University of Amazonas, UFAM-PPGI, Manaus-Amazonas 69067-005, Brazil. souzavinicius1993@gmail.com.
  • Guimarães da Cruz R; Federal University of Amazonas, UFAM-PPGEE, Manaus-Amazonas 69067-005, Brazil. robsoncruz.ufam@gmail.com.
  • Mesquita Vidal Martinez de Lucena J; Federal Institute of Amazonas, IFAM-CMC, Amazonas, Brazil. juliana.lucena@ifam.edu.br.
  • Jazdi N; Institute of Industrial Automation and Software Systems, The University of Stuttgart, 70174 Stuttgart, Germany. Nasser.Jazdi@ias.uni-stuttgart.de.
  • Ferreira de Lucena Junior V; Federal University of Amazonas, UFAM-PPGI, Manaus-Amazonas 69067-005, Brazil. vicente@ufam.edu.br.
Sensors (Basel) ; 19(20)2019 Oct 18.
Article em En | MEDLINE | ID: mdl-31635394
This paper presents an intelligent system designed to increase the treatment adherence of hypertensive patients. The architecture was developed to allow communication among patients, physicians, and families to determine each patient's rate assertion of medication intake time and their self-monitoring of blood pressure. Concerning the medication schedule, the system is designed to follow a predefined prescription, adapting itself to undesired events, such as mistakenly taking medication or forgetting to take medication on time. When covering the blood pressure measurement, it incorporates best medical practices, registering the actual values in recommended frequency and form, trying to avoid the known "white-coat effect." We assume that taking medicine precisely and measuring blood pressure correctly may lead to good adherence to the treatment. The system uses commercial consumer electronic devices and can be replicated in any home equipped with a standard personal computer and Internet access. The resulting architecture has four layers. The first is responsible for adding electronic devices that typically exist in today's homes to the system. The second is a preprocessing layer that filters the data generated from the patient's behavior. The third is a reasoning layer that decides how to act based on the patient's activities observed. Finally, the fourth layer creates messages that should drive the reactions of all involved actors. The reasoning layer takes into consideration the patient's schedule and medication-taking activity data and uses implicit algorithms based on the J48, RepTree, and RandomTree decision tree models to infer the adherence. The algorithms were first adjusted using one academic machine learning and data mining tool. The system communicates with users through smartphones (anytime and anywhere) and smart TVs (in the patient's home) by using the 3G/4G and WiFi infrastructure. It interacts automatically through social networks with doctors and relatives when changes or mistakes in medication intake and blood pressure mean values are detected. By associating the blood pressure data with the history of medication intake, our system can indicate the treatment adherence and help patients to achieve better treatment results. Comparisons with similar research were made, highlighting our findings.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Determinação da Pressão Arterial / Adesão à Medicação / Hipertensão Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Sensors (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Determinação da Pressão Arterial / Adesão à Medicação / Hipertensão Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Sensors (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça